アリゾナ州における頭頸部扁平上皮癌の臨床試験
アリゾナ州内の拠点で、頭頸部扁平上皮癌に関する18件の研究が参加者を募集しています。
アリゾナ州内の都市
公式研究テキスト（英語）
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
- Arizona Center for Cancer Care - Gilbert, Gilbert
- Arizona Center for Cancer Care-Peoria, Peoria
- Arizona Center for Cancer Care - Biltmore, Phoenix
- 他6件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06992427FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Site #0147, Phoenix
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06788990Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #67, Phoenix
- Exelixis Clinical Site #1, Tucson
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Gilbert
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05877599BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Mayo Clinic Hospital in Arizona, Phoenix
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05136196A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Ironwood Cancer and Research Center, Chandler
- University of Arizona Cancer Center, Tucson
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07276399Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- Cancer Center at Saint Joseph's, Phoenix
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT02734537ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Ironwood Cancer & Research Centers, Chandler
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- Banner MD Anderson Cancer Center, Gilbert
- Mayo Clinic Hospital in Arizona, Phoenix
- Banner University Medical Center - Tucson, Tucson
- 他1件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Arizona Center for Cancer Care - Gilbert, Gilbert
- Arizona Center for Cancer Care-Peoria, Peoria
- Arizona Center for Cancer Care - Phoenix, Phoenix
- 他3件
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06532279A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
- Mayo Foundation for Medical Education and Research - Mayo Cl, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/29更新 · NCT06747585Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- University of Arizona Cancer Center - Tucson /ID# 262698, Tucson
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/04更新 · NCT04777994A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Banner MD Anderson Cancer Center, Gilbert
- The University of Arizona Cancer Center, Tucson
被験者募集中第3相
18歳以上 · 全性別 · 2026/04/09更新 · NCT06064877A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- HonorHealth Research Institute, Scottsdale
- The University of Arizona Cancer Center, Tucson
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT06778863A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 111, Tucson
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/21更新 · NCT05914116A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Banner MD Anderson Cancer Center, Gilbert
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/09/09更新 · NCT06682793Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- HonorHealth Research Institute, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2024/11/15更新 · NCT04787042A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
- Mayo Clinic Arizona, Phoenix
- HonorHealth Research and Innovation Institute, Scottsdale
被験者募集中第1相
18歳以上 · 全性別 · 2024/09/24更新 · NCT06259552ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。